Business Case

Developed a market map to inform a mid-size GTx manufacturer’s commercial strategy and launch planning

Our client, a mid-sized pharmaceutical company developing a GTx to be indicated for a rare disease, aimed to understand market nuances to strategically position a novel therapeutic agent. To ensure our client could launch with a complete understanding of the market, LSC embarked on a comprehensive approach, beginning with secondary research to develop hypotheses of target physicians and patients, continuing to analysis of prescription and claims data, and finally engaging key stakeholders in qualitative market research, powered by our in-house market research capabilities. This approach resulted in a detailed market map, spotlighting not only areas of unmet need and the product value proposition receptivity, but also offering valuable insights to shape our client’s commercial strategy and customer targeting efforts.